| 1 |
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Daniel J. Klionsky et al. · Autophagy
Open access2,930 authors |
2 Jan 2021 |
2,743 |
| 2 |
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Samantha E Meltzer-Brody, Helen Colquhoun, Robert A. Riesenberg et al. · The Lancet
|
31 Aug 2018 |
800 |
| 3 |
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
Adriana E. Tron et al. · Nature Communications
Open access |
11 Dec 2018 |
496 |
| 4 |
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
Stephen Kanes, Helen Colquhoun, Handan Gunduz‐Bruce et al. · The Lancet
|
13 Jun 2017 |
484 |
| 5 |
Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating Disorder
Susan L. McElroy, James I. Hudson, James Earl Mitchell et al. · JAMA Psychiatry
|
14 Jan 2015 |
321 |
| 6 |
Impact of Cross-Coupling Reactions in Drug Discovery and Development
Melissa J. Buskes, Marı́a-Jesús Blanco · Molecules
Open access |
31 Jul 2020 |
305 |
| 7 |
Effect of Zuranolone vs Placebo in Postpartum Depression
Kristina M. Deligiannidis, Samantha E Meltzer-Brody, Handan Gunduz‐Bruce et al. · JAMA Psychiatry
Open access |
30 Jun 2021 |
274 |
| 8 |
The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator ofN-Methyl-d-Aspartate Receptors
Steven M. Paul, James Doherty, Albert J. Robichaud et al. · Journal of Neuroscience
Open access |
30 Oct 2013 |
269 |
| 9 |
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
Ingo K. Mellinghoff, Min Lu, Patrick Yung Wen et al. · Nature Medicine
Open access |
23 Feb 2023 |
241 |
| 10 |
Trial of SAGE-217 in Patients with Major Depressive Disorder
Handan Gunduz-Bruce, Christopher Silber, Inder Kaul et al. · New England Journal of Medicine
|
4 Sep 2019 |
234 |
| 11 |
The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)
Paul E. Greenberg, A.S. Chitnis, Derek J. Louie et al. · Advances in Therapy
Open access |
30 Jul 2023 |
221 |
| 12 |
Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
Michael P. Clark et al. · Journal of Medicinal Chemistry
Open access |
14 Jul 2014 |
219 |
| 13 |
Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility
Matthew R. Naylor, Andrew M. Ly, Mason J. Handford et al. · Journal of Medicinal Chemistry
|
5 Nov 2018 |
207 |
| 14 |
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo
Janeta V. Popovici-Müller, Jeffrey O. Saunders, Francesco G. Salituro et al. · ACS Medicinal Chemistry Letters
Open access |
17 Sep 2012 |
201 |
| 15 |
Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression
Miranda Cooper, H. Kilvert, Paul Hodgkins et al. · CNS Drugs
Open access |
Oct 2019 |
192 |
| 16 |
Costs, length of stay, and mortality of super‐refractory status epilepticus: A population‐based study from Germany
Adam Strzelczyk, Sonja Ansorge, Jana Hapfelmeier et al. · Epilepsia
|
6 Jul 2017 |
192 |
| 17 |
Cyclic peptide natural products chart the frontier of oral bioavailability in the pursuit of undruggable targets
Matthew R. Naylor, Andrew T. Bockus, Marı́a-Jesús Blanco et al. · Current Opinion in Chemical Biology
Review |
30 May 2017 |
189 |
| 18 |
Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database
Jean‐Louis Vincent, Nathan D. Nielsen, Nathan Ivan Shapiro et al. · Annals of Intensive Care
Open access |
2018 |
185 |
| 19 |
The 2016 ACR Commission on Human Resources Workforce Survey
Edward I. Bluth, Swati Bansal · Journal of the American College of Radiology
|
4 Aug 2016 |
173 |
| 20 |
Neuroactive steroids for the treatment of status epilepticus
Michael A. Rogawski, Carlos M. Loya, Kiran Reddy et al. · Epilepsia
Open access |
Sep 2013 |
161 |
| 21 |
Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
Stephen Kanes, Helen Colquhoun, James Doherty et al. · Human Psychopharmacology Clinical and Experimental
Open access |
Mar 2017 |
151 |
| 22 |
Impact of Major Depressive Disorder on Comorbidities
Alix M. Arnaud, Teri S. Brister, Ken Duckworth et al. · The Journal of Clinical Psychiatry
Open access |
18 Oct 2022 |
149 |
| 23 |
Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
Samantha E Meltzer-Brody, Stephen Kanes · Neurobiology of Stress
Open access |
3 Feb 2020 |
134 |
| 24 |
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator
Alison L. Althaus, Michael A. Ackley, Gabriel M. Belfort et al. · Neuropharmacology
Open access |
22 Sep 2020 |
132 |
| 25 |
25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner
Man Ying Wong, Michael Lewis, James Doherty et al. · Journal of Neuroinflammation
Open access |
17 Jun 2020 |
124 |
| 26 |
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) A Receptor
Gabriel Martinez Botella, Francesco G. Salituro, Boyd L. Harrison et al. · Journal of Medicinal Chemistry
Open access |
28 Jul 2017 |
123 |
| 27 |
Pediatric super‐refractory status epilepticus treated with allopregnanolone
Eileen M. Broomall, JoAnne E. Natale, Michele Grimason et al. · Annals of Neurology
Open access |
Nov 2014 |
120 |
| 28 |
Allopregnanolone Mediates Affective Switching Through Modulation of Oscillatory States in the Basolateral Amygdala
Pantelis Antonoudiou, Phillip L.W. Colmers, Najah L. Walton et al. · Biological Psychiatry
Open access |
27 Jul 2021 |
119 |
| 29 |
Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial
A. Stewart Campbell, Brittany D. Needham, Christopher R. Meyer et al. · Nature Medicine
Open access |
14 Feb 2022 |
108 |
| 30 |
Brexanolone as adjunctive therapy in super‐refractory status epilepticus
Eric S. Rosenthal, Jan Claassen, Mark S. Wainwright et al. · Annals of Neurology
Open access |
5 Aug 2017 |
100 |
| 31 |
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
Jamie Adams et al. · npj Parkinson s Disease
Open access |
17 Apr 2023 |
98 |
| 32 |
Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
Michelle Pirruccello, Justin Jackson, Stefan Wawersik et al. · Scientific Reports
Open access |
29 Jan 2018 |
94 |
| 33 |
AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study
Robert E. Litman, Mark A. Smith, James Doherty et al. · Schizophrenia Research
|
26 Feb 2016 |
87 |
| 34 |
Different oxysterols have opposing actions at N-methyl-d-aspartate receptors
Andrew J. Linsenbardt, Amanda Taylor, Christine M. Emnett et al. · Neuropharmacology
Open access |
27 May 2014 |
87 |
| 35 |
Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis
Francesco Mannara, Marija Radosevic, Jesús Planagumà et al. · Brain
Open access |
11 Jun 2020 |
84 |
| 36 |
Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population‐based study on German health insurance data
Susanne Schubert‐Bast, Johann Philipp Zöllner, Sonja Ansorge et al. · Epilepsia
|
13 Apr 2019 |
78 |
| 37 |
Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism
Amit Modgil, Manasa L. Parakala, Michael A. Ackley et al. · Neuropharmacology
Open access |
16 Oct 2016 |
77 |
| 38 |
Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program
Cynthia Neill Epperson, David R. Rubinow, Samantha E Meltzer-Brody et al. · Journal of Affective Disorders
Open access |
30 Sep 2022 |
76 |
| 39 |
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
Erica M. Richards, Daniel C. Mathews, David A. Luckenbaugh et al. · Psychopharmacology
Open access |
4 Jan 2016 |
76 |
| 40 |
Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities
Bingsong Han, Francesco G. Salituro, Marı́a-Jesús Blanco · ACS Medicinal Chemistry Letters
Open access |
10 Mar 2020 |
73 |
| 41 |
2018 ACR Commission on Human Resources Workforce Survey
Claire E. Bender, Swati Bansal, Darcy J. Wolfman et al. · Journal of the American College of Radiology
|
10 Feb 2019 |
70 |
| 42 |
Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
Geneviève Gauthier, Annie Guérin, Maryia Zhdanava et al. · BMC Psychiatry
Open access |
19 Jun 2017 |
70 |
| 43 |
Zuranolone in Major Depressive Disorder
Anita H. Clayton, Robert A. Lasser, Indrani M. Nandy et al. · The Journal of Clinical Psychiatry
Open access |
17 Feb 2023 |
69 |
| 44 |
Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor
Supraja Narasimhan, Elizabeth Zulick, Olga Novikov et al. · International Journal of Molecular Sciences
Open access |
7 May 2018 |
66 |
| 45 |
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas
Raphael Koch, Amanda L. Christie, Jennifer Leigh Crombie et al. · Blood
Open access |
30 Nov 2018 |
65 |
| 46 |
A Novel, Synthetic, Neuroactive Steroid Is Effective at Decreasing Depression-Like Behaviors and Improving Maternal Care in Preclinical Models of Postpartum Depression
Laverne Camille Melón, Rebecca Hammond, Michael Lewis et al. · Frontiers in Endocrinology
Open access |
23 Nov 2018 |
63 |
| 47 |
Essential tremor patients experience significant burden beyond tremor: A systematic literature review
Margaret E. Gerbasi, Shruti Nambiar, Spencer Reed et al. · Frontiers in Neurology
ReviewOpen access |
22 Jul 2022 |
62 |
| 48 |
VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease
Sudipta Mahajan, James K. Hogan, Dina Shlyakhter et al. · Journal of Pharmacology and Experimental Therapeutics
|
12 Mar 2015 |
62 |
| 49 |
SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies
Ethan C. Hoffmann, George G. Nomikos, Inder Kaul et al. · Clinical Pharmacokinetics
Open access |
24 Jul 2019 |
59 |
| 50 |
The future of fungi: threats and opportunities
Nicola T. Case et al. · G3 Genes Genomes Genetics
Open access |
30 Sep 2022 |
57 |